Kintara Therapeutics Inc (KTRA) – it’s time to buy. Check out key Indicators

In yesterday’s Wall Street session, Kintara Therapeutics Inc (NASDAQ:KTRA) shares traded at $0.38, down -3.01% from the previous session. As of this writing, 2 analysts cover Kintara Therapeutics Inc (NASDAQ:KTRA). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $14.00 and a […]